Your browser doesn't support javascript.
loading
Measurable residual disease does not preclude prolonged progression-free survival in CLL treated with ibrutinib.
Wang, Xin Victoria; Hanson, Curtis A; Tschumper, Renee C; Lesnick, Connie E; Braggio, Esteban; Paietta, Elisabeth M; O'Brien, Susan; Barrientos, Jacqueline C; Leis, Jose Francisco; Zhang, Cong Christine; Coutre, Steven E; Barr, Paul M; Cashen, Amanda F; Mato, Anthony R; Singh, Avina K; Mullane, Michael P; Erba, Harry; Stone, Richard; Litzow, Mark R; Tallman, Martin S; Shanafelt, Tait D; Kay, Neil E.
Afiliação
  • Wang XV; Department of Data Science, Dana-Farber Cancer Institute, Boston, MA.
  • Hanson CA; Department of Biostatistics, Harvard T. H. Chan School of Public Health, Boston, MA.
  • Tschumper RC; Division of Hematology and Department of Internal Medicine, Mayo Clinic, Rochester, MN.
  • Lesnick CE; Division of Hematology and Department of Internal Medicine, Mayo Clinic, Rochester, MN.
  • Braggio E; Division of Hematology and Department of Internal Medicine, Mayo Clinic, Rochester, MN.
  • Paietta EM; Department of Hematology/Oncology, Mayo Clinic in Arizona, Scottsdale, AZ.
  • O'Brien S; Department of Oncology, Montefiore Medical Center, Brooklyn, NY.
  • Barrientos JC; Chao Family Comprehensive Cancer Center, University of California Irvine Medical Center, Irvine, CA.
  • Leis JF; Northwell Health Center for Advanced Medicine, New Hyde Park, NY.
  • Zhang CC; Division of Hematology/Oncology, Department of Internal Medicine, Mayo Clinic in Arizona, Phoenix, AZ.
  • Coutre SE; Department of Hematology/Oncology, Kaiser Permanente National Cancer Institute Community Oncology Research Program (NCORP)/The Permanente Medical Group, Fresno, CA.
  • Barr PM; Department of Medicine, Stanford University, Stanford, CA.
  • Cashen AF; Department of Medicine, Rochester University, Rochester, NY.
  • Mato AR; Department of Medicine, Washington University School of Medicine, St Louis, MO.
  • Singh AK; CLL Program, Memorial Sloan-Kettering Cancer Center, New York, NY.
  • Mullane MP; Fairview Ridges Hospital, Burnsville, MN.
  • Erba H; Aurora Cancer Care-Milwaukee West, Milwaukee, WI.
  • Stone R; Department of Medicine, Duke University Medical Center, Durham, NC.
  • Litzow MR; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA; and.
  • Tallman MS; Division of Hematology and Department of Internal Medicine, Mayo Clinic, Rochester, MN.
  • Shanafelt TD; Leukemia Service, Memorial Sloan-Kettering Cancer Center, New York, NY.
  • Kay NE; Department of Medicine, Stanford University, Stanford, CA.
Blood ; 138(26): 2810-2827, 2021 12 30.
Article em En | MEDLINE | ID: mdl-34407545
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Piperidinas / Adenina / Leucemia Linfocítica Crônica de Células B / Neoplasia Residual / Inibidores de Proteínas Quinases Idioma: En Ano de publicação: 2021 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Piperidinas / Adenina / Leucemia Linfocítica Crônica de Células B / Neoplasia Residual / Inibidores de Proteínas Quinases Idioma: En Ano de publicação: 2021 Tipo de documento: Article